Junchao Tong And NotAutriche
List of bibliographic references
Number of relevant bibliographic references: 8.Ident. | Authors (with country if any) | Title |
---|---|---|
000116 | Stephen J. Kish [Canada] ; Isabelle Boileau [Canada] ; Russell C. Callaghan [Canada] ; Junchao Tong [Canada] | Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence. |
000398 | Doris E. Payer ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia |
000470 | Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
001685 | Junchao Tong [Canada] ; Isabelle Boileau [Canada] ; Yoshiaki Furukawa [Japon] ; Li-Jan Chang [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Stephen J. Kish [Canada] | Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies |
002179 | Isabelle Boileau [Canada] ; Pablo Rusjan ; Sylvain Houle ; Diana Wilkins ; Junchao Tong ; Peter Selby ; Mark Guttman ; Jean A. Saint-Cyr ; Alan A. Wilson ; Stephen J. Kish | Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? |
002238 | Stephen J. Kish [Canada, Niger] ; Junchao Tong [Canada] ; Oleh Hornykiewicz [Canada] ; Ali Rajput [Canada] ; Li-Jan Chang [Canada] ; Mark Guttman [Canada] ; Yoshiaki Furukawa [Canada] | Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease |
002737 | Junchao Tong [Canada] ; Oleh Hornykiewicz ; Stephen J. Kish | Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. |
002C84 | Junchao Tong [Canada] ; Paul S. Fitzmaurice ; Lee Cyn Ang [Royaume-Uni] ; Yoshiaki Furukawa [Canada] ; Mark Guttman ; Stephen J. Kish | Brain dopamine‐stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy |
This area was generated with Dilib version V0.6.29. |